A Study to Evaluate the Impact of Omeprazole on the Pharmacokinetics of Sotorasib Co-administered With an Acidic Beverage in Healthy Volunteers
Completed · Phase 1
Conditions studied: Healthy Volunteers
In brief
The primary objective of the study is to evaluate the effects of omeprazole (a proton-pump inhibitor) and an acidic beverage (Coca-Cola) on sotorasib pharmacokinetics (PK) when administered orally in healthy volunteers.
Key facts
- Study ID
- NCT05497557
- Run by
- Amgen
- People needed
- 16
- Starts
- 2022-07-14
- Expected to finish
- 2022-09-08
- Last updated by the study team
- 2024-01-19
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.
Where it is running
- Labcorp Clinical Research Unit Inc. — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.